
|

| |
Track the *RXCAN Index |
 |
|
 | Cancer Stocks (*RXCAN) |
| |
Cancer Ideas |
|
|
|
Cancer Performance |
|
|
|
Cancer Community |
|
| |
|
Index Description: These medical firms have significant exposure to cancer detection and treatment
|
|
|
|
|
Today:
1-month:
All-time:
|
-1.4%
-0.3%
+15.5%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.8%
-4.5%
-3.5%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$2.2B
17.6
0.2%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| AEZS |
$2.00 |
-0.03 |
-1.5% |
50,003 |
75% |
$51.4M |
- |
18% |
-64% |
No Alerts/News
|
|
|
| ARIA |
$19.56 |
+0.12 |
+0.6% |
1,030,944 |
90% |
$3.5B |
- |
29% |
-23% |
No Alerts/News
|
|
|
| ARRY |
$5.73 |
+0.07 |
+1.2% |
207,752 |
44% |
$660.4M |
- |
91% |
-13% |
No Alerts/News
|
|
|
| AVEO |
$2.61 |
-0.09 |
-3.3% |
1,863,511 |
145% |
$139.9M |
- |
16% |
-81% |
2 Alerts (1 News) - View
|
|
|
| BCRX |
$1.61 |
-0.05 |
-3.0% |
355,342 |
56% |
$85.3M |
- |
49% |
-67% |
1 Alert (0 News) - View
|
|
|
| CTIC |
$1.22 |
0.00 |
0.0% |
201,723 |
73% |
$137.4M |
- |
20% |
-74% |
No Alerts/News
|
|
|
| CVM |
$0.25 |
0.00 |
-0.4% |
116,090 |
31% |
$77.6M |
- |
22% |
-46% |
No Alerts/News
|
|
|
| CYCC |
$3.24 |
+0.06 |
+1.9% |
226,409 |
217% |
$34.4M |
- |
11% |
-60% |
2 Alerts (0 News) - View
|
|
|
| CYTK |
$1.13 |
-0.05 |
-4.0% |
141,405 |
25% |
$172.8M |
- |
99% |
-22% |
No Alerts/News
|
|
|
| DCTH |
$0.42 |
0.00 |
-0.5% |
890,181 |
73% |
$38.7M |
- |
13% |
-82% |
No Alerts/News
|
|
|
| DNDN |
$3.89 |
-0.02 |
-0.6% |
609,947 |
35% |
$616.8M |
- |
5% |
-51% |
No Alerts/News
|
|
|
| ENZN |
$3.16 |
0.00 |
0.0% |
23,713 |
15% |
$138.1M |
- |
7% |
-58% |
No Alerts/News
|
|
|
| EXEL |
$4.73 |
-0.04 |
-0.8% |
319,078 |
55% |
$876.6M |
- |
13% |
-32% |
No Alerts/News
|
|
|
| GERN |
$1.11 |
-0.01 |
-0.9% |
170,178 |
71% |
$146.0M |
- |
22% |
-63% |
No Alerts/News
|
|
|
| GNBT |
$0.03 |
-0.01 |
-16.6% |
5,844,327 |
873% |
$19.4M |
- |
57% |
-72% |
1 Alert (0 News) - View
|
|
|
| GTXI |
$6.31 |
-0.17 |
-2.6% |
257,970 |
159% |
$407.5M |
- |
141% |
-12% |
1 Alert (0 News) - View
|
|
|
| HSP |
$34.90 |
-0.28 |
-0.8% |
125,342 |
26% |
$5.8B |
- |
22% |
-8% |
1 Alert (1 News) - View
|
|
|
| ISIS |
$20.58 |
-0.06 |
-0.3% |
287,663 |
45% |
$2.1B |
- |
172% |
-11% |
No Alerts/News
|
|
|
| KERX |
$8.00 |
-0.03 |
-0.4% |
371,361 |
46% |
$656.1M |
- |
416% |
-20% |
No Alerts/News
|
|
|
| MEIP |
$8.32 |
0.00 |
0.0% |
8,026 |
31% |
$125.1M |
- |
320% |
-37% |
No Alerts/News
|
|
|
| MELA |
$1.12 |
+0.01 |
+0.9% |
116,056 |
62% |
$47.7M |
- |
10% |
-74% |
1 Alert (0 News) - View
|
|
|
| MSTX |
$0.67 |
-0.02 |
-2.6% |
54,205 |
81% |
$31.9M |
- |
49% |
-27% |
No Alerts/News
|
|
|
| MYGN |
$31.38 |
-0.81 |
-2.5% |
413,425 |
86% |
$2.5B |
- |
43% |
-10% |
1 Alert (0 News) - View
|
|
|
| ONTY |
$1.95 |
0.00 |
0.0% |
57,152 |
14% |
$111.5M |
- |
14% |
-69% |
No Alerts/News
|
|
|
| ONXX |
$94.55 |
-1.65 |
-1.7% |
110,481 |
28% |
$6.9B |
- |
129% |
-7% |
No Alerts/News
|
|
|
| PDLI |
$8.30 |
-0.04 |
-0.5% |
305,059 |
48% |
$1.1B |
7.2% |
34% |
-2% |
No Alerts/News
|
|
|
| PGNX |
$3.97 |
-0.09 |
-2.2% |
19,411 |
17% |
$207.2M |
- |
182% |
-64% |
No Alerts/News
|
|
|
| PPHM |
$1.69 |
+0.07 |
+4.5% |
1,291,201 |
135% |
$216.7M |
- |
301% |
-69% |
No Alerts/News
|
|
|
| QLTI |
$7.76 |
-0.13 |
-1.6% |
16,803 |
57% |
$398.6M |
- |
23% |
-15% |
No Alerts/News
|
|
|
| REGN |
$248.26 |
-6.61 |
-2.6% |
204,795 |
35% |
$24.9B |
- |
131% |
-13% |
No Alerts/News
|
|
|
| SGEN |
$34.76 |
-0.59 |
-1.7% |
207,531 |
72% |
$4.2B |
- |
83% |
-11% |
No Alerts/News
|
|
|
| TELK |
$1.32 |
0.00 |
0.0% |
5,800 |
65% |
$6.0M |
- |
21% |
-82% |
No Alerts/News
|
|
|
| UTHR |
$65.96 |
-1.65 |
-2.4% |
185,440 |
66% |
$3.3B |
- |
57% |
-5% |
No Alerts/News
|
|
|
| VRTX |
$77.40 |
-1.08 |
-1.4% |
342,799 |
28% |
$17.1B |
- |
101% |
-12% |
No Alerts/News
|
|
|
| XOMA |
$4.07 |
-0.06 |
-1.4% |
187,929 |
66% |
$342.3M |
- |
81% |
-7% |
No Alerts/News
|
|
|
|
Is this index incomplete or incorrect?
Got an idea for a new Index?
|
|
|
| |

|
| |
|
| |

|
| |
Wockhardt Drug Filings Seen Delayed After U.S. FDA Alert HSP
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 08:33AM from (www.bloomberg.com) Wockhardt Ltd. (WPL), an Indian maker of insulin and hepatitis vaccines, will not win new drug approvals this year for about
Flag
Post a comment
U.S. Stock Futures Decline, Signaling Third Day of Losses GPS AVEO TITN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 05:55AM from (www.bloomberg.com) U.S. stock futures fell, indicating the Standard & Poor’s 500 Index will retreat for a third day, as investors awaited a report on durable-goods orders.
Flag
Post a comment
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering CYCC CYCCP
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 21, 04:13PM from (globenewswire.com) BERKELEY HEIGHTS, N.J., May 21, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel
Flag
Post a comment
Dupilumab, a New Drug, May Help Some Asthmatics REGN SNY
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 21, 04:12PM from (www.nytimes.com) The number of asthma attacks or other outbreaks of symptoms decreased by 87 percent in those getting the drug, Dupilumab,
Flag
Post a comment
$307,000-a-year Vertex Drug: Billions in Sales? VRTX
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 20, 12:50PM from (ycharts.com) Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to come:
Flag
Post a comment
UK to Pilot Illumina Genetic Test for Breast, Ovarian Cancer MYGN ILMN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 20, 10:07AM from (www.bloomberg.com) The U.K. is piloting a new genetic test developed by Illumina Inc. (ILMN) to help cancer patients and their doctors better
Flag
Post a comment
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index PGNX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 17, 05:43PM from (globenewswire.com) TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has
Flag
Post a comment
Mid-Morning Market Update: Housing Starts Plummet, Initial Jobless Claims Rise AMD CSCO HALO DRYS ONTY
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 16, 10:51AM from (www.benzinga.com) Following the market opening Wednesday, the Dow traded down 0.12 percent to 15,257.00, while the NASDAQ rose 0.15 percent
Flag
Post a comment
Top New Biotech Ideas from PropThink CELG REGN CBST VPHM ONXX AVEO MAKO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)
Flag
Post a comment
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials ARRY
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 16, 02:18AM from (www.bloomberg.com) AstraZeneca Plc (AZN) will move three experimental cancer treatments into late-stage development as generic competition for its best-selling drugs intensifies.
Flag
Post a comment
Company That Sells Angelina Jolie’s Blood Test MYGN MON
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 15, 03:18PM from (ycharts.com) Shares of Myriad Genetics (MYGN) spiked higher yesterday to hit their highest levels on record since mid-2009, as seen in
Flag
Post a comment
What We're Reading ~ Analytical Links 5/15/13 VZ VOD DLTR HSP FLT
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com) Meb Faber's new book: Shareholder Yield [Meb Faber]
Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
Flag
Post a comment
Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo DNDN
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 11:15AM from (247wallst.com) Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer
Flag
Post a comment
Deutsche Bank Firm on Biotech Stocks to Buy AMGN CELG REGN BIIB VRTX GILD ALXN ONXX DB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com) Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and
Flag
Post a comment
Roche Wins FDA Approval for Test to Target Lung Cancer MYGN QGEN
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 05:43PM from (www.bloomberg.com) Roche Holding AG (ROG), the world’s biggest maker of cancer drugs, won U.S. approval to sell a gene mutation test that
Flag
Post a comment
Myriad Genetics, Angelina Jolie, and Genomics in Focus MYGN GHDX ROSG
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 01:58PM from (247wallst.com) Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic
Flag
Post a comment
|
|
|